Biology of Blood and Marrow Transplantation
Volume 13, Issue 5 , Pages 517-520 , May 2007

Increased Risk of Bone Loss without Fracture Risk in Long-Term Survivors after Allogeneic Stem Cell Transplantation

Received 20 December 2006 ,Accepted 29 January 2007.

References 

  1. Socié G, Stone JV, Wingard JR, et al. Late Effects Working Committee of the International Bone Marrow Transplant Registry Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341:14–21
  2. Petryk A, Bergemann TL, Polga KM, et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab. 2006;91:899–905
  3. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–6606
  4. Schulte CM, Beelen DW. Low pretransplant bone-mineral density and rapid bone loss do not increase risk for avascular osteonecrosis after allogeneic hematopoietic stem cell transplantation. Transplantation. 2005;79:1748–1755
  5. Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33:435–441
  6. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom. 2004;7:17–26
  7. Kanis JA, Gluer CC Committee of Scientific Advisors, International Osteoporosis Foundation. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int. 2000;11:192–202
  8. Robin M, Guardiola P, Devergie A, et al. A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors. Leukemia. 2005;19:1613–1620
  9. Socié G, Mary JY, Esperou H, et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2001;113:194–201
  10. Kananen K, Volin L, Laitinen K, et al. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab. 2005;90:3877–3885
  11. Tauchmanova L, De Simone G, Musella T, et al. Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;37:81–88
  12. Grigg AP, Shuttleworth P, Reynolds J, et al. Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab. 2006;91:3835–3843
  13. Schulte CM, Beelen DW. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood. 2004;103:3635–3643
  14. Kerschan-Schindl K, Mitterbauer M, Fureder W, et al. Bone metabolism in patients more than five years after bone marrow transplantation. Bone Marrow Transplant. 2004;34:491–496

 The first two authors contributed equally to this work.

PII: S1083-8791(07)00144-9

doi: 10.1016/j.bbmt.2007.01.085

Biology of Blood and Marrow Transplantation
Volume 13, Issue 5 , Pages 517-520 , May 2007

Article Tools

* Image Usage & Resolution